Sadhu provides an update on the state of the stem cell and islet cell therapy landscapes, highlighting encouraging developments in insulin independence.
Archana Sadhu, MD
Advertisement
Archana Sadhu, MD, is the director of transplant endocrinology, pancreas transplantation, and the system diabetes program at Houston Methodist.
Articles by Archana Sadhu, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy
2
Weight Loss, Not GLP-1 Therapy, Predicts Systolic Blood Pressure Change in Diabetes
3
Tirzepatide (Zepbound) Improves Kidney Transplant Eligibility in T2D and CKD With Severe Obesity
4
Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy
5